HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test
A new genotyping-based DNA assay (Digene LQ(®)) was developed recently. The primary aim was to assess the distribution of HPV types using this new assay in atypical squamous cells of undeterminate significance (ASCUS). The secondary aim was to correlate the HPV types with the severity of the disease...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668127/ https://www.ncbi.nlm.nih.gov/pubmed/23299934 http://dx.doi.org/10.1007/s00705-012-1584-4 |
_version_ | 1782271572900315136 |
---|---|
author | Halfon, Philippe Lindemann, Maria Luisa Mateos Raimondo, Audrey Ravet, Sophie Camus, Claire Khiri, Hacène Pénaranda, Guillaume Sideri, Mario Sandri, Maria Teresa |
author_facet | Halfon, Philippe Lindemann, Maria Luisa Mateos Raimondo, Audrey Ravet, Sophie Camus, Claire Khiri, Hacène Pénaranda, Guillaume Sideri, Mario Sandri, Maria Teresa |
author_sort | Halfon, Philippe |
collection | PubMed |
description | A new genotyping-based DNA assay (Digene LQ(®)) was developed recently. The primary aim was to assess the distribution of HPV types using this new assay in atypical squamous cells of undeterminate significance (ASCUS). The secondary aim was to correlate the HPV types with the severity of the disease. The study population comprised 376 ASCUS women. The women were all Hybrid Capture II (HCII) positive and were admitted in three European referral gynecology clinics between 2007 and 2010. A colposcopy with histological examination was performed in all these patients. HPV 16 was typed in 40 % of patients, HPV 18 in 7 %, and HPV 31 in 17 %, and 18 % of patients had mixed genotypes. Patients aged over 30 more often had the HPV 16 genotype than patients aged under 30 (29 % vs. 11 %, chi-square test p < 0.001). The risk of cervical intra-epithelial neoplasia of grade 2 or more (CIN2 +) when HPV 18 positive is lower than the probability associated with HPV 16 or HPV 31: 28 % vs. 58 % and 52 %, respectively (chi-square test, p = 0.005 and p = 0.05, respectively). The Digene LQ(®), a new sequence-specific hybrid capture sample preparation, is fast and efficient and allows high-throughput genotyping of 18 HR HPV types by PCR compared to traditional non-sequence-specific sample preparation methods. |
format | Online Article Text |
id | pubmed-3668127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-36681272013-06-03 HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test Halfon, Philippe Lindemann, Maria Luisa Mateos Raimondo, Audrey Ravet, Sophie Camus, Claire Khiri, Hacène Pénaranda, Guillaume Sideri, Mario Sandri, Maria Teresa Arch Virol Original Article A new genotyping-based DNA assay (Digene LQ(®)) was developed recently. The primary aim was to assess the distribution of HPV types using this new assay in atypical squamous cells of undeterminate significance (ASCUS). The secondary aim was to correlate the HPV types with the severity of the disease. The study population comprised 376 ASCUS women. The women were all Hybrid Capture II (HCII) positive and were admitted in three European referral gynecology clinics between 2007 and 2010. A colposcopy with histological examination was performed in all these patients. HPV 16 was typed in 40 % of patients, HPV 18 in 7 %, and HPV 31 in 17 %, and 18 % of patients had mixed genotypes. Patients aged over 30 more often had the HPV 16 genotype than patients aged under 30 (29 % vs. 11 %, chi-square test p < 0.001). The risk of cervical intra-epithelial neoplasia of grade 2 or more (CIN2 +) when HPV 18 positive is lower than the probability associated with HPV 16 or HPV 31: 28 % vs. 58 % and 52 %, respectively (chi-square test, p = 0.005 and p = 0.05, respectively). The Digene LQ(®), a new sequence-specific hybrid capture sample preparation, is fast and efficient and allows high-throughput genotyping of 18 HR HPV types by PCR compared to traditional non-sequence-specific sample preparation methods. Springer Vienna 2013-01-09 2013 /pmc/articles/PMC3668127/ /pubmed/23299934 http://dx.doi.org/10.1007/s00705-012-1584-4 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by/2.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Original Article Halfon, Philippe Lindemann, Maria Luisa Mateos Raimondo, Audrey Ravet, Sophie Camus, Claire Khiri, Hacène Pénaranda, Guillaume Sideri, Mario Sandri, Maria Teresa HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test |
title | HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test |
title_full | HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test |
title_fullStr | HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test |
title_full_unstemmed | HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test |
title_short | HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test |
title_sort | hpv genotype distribution according to severity of cervical neoplasia using the digene hpv genotyping lq test |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668127/ https://www.ncbi.nlm.nih.gov/pubmed/23299934 http://dx.doi.org/10.1007/s00705-012-1584-4 |
work_keys_str_mv | AT halfonphilippe hpvgenotypedistributionaccordingtoseverityofcervicalneoplasiausingthedigenehpvgenotypinglqtest AT lindemannmarialuisamateos hpvgenotypedistributionaccordingtoseverityofcervicalneoplasiausingthedigenehpvgenotypinglqtest AT raimondoaudrey hpvgenotypedistributionaccordingtoseverityofcervicalneoplasiausingthedigenehpvgenotypinglqtest AT ravetsophie hpvgenotypedistributionaccordingtoseverityofcervicalneoplasiausingthedigenehpvgenotypinglqtest AT camusclaire hpvgenotypedistributionaccordingtoseverityofcervicalneoplasiausingthedigenehpvgenotypinglqtest AT khirihacene hpvgenotypedistributionaccordingtoseverityofcervicalneoplasiausingthedigenehpvgenotypinglqtest AT penarandaguillaume hpvgenotypedistributionaccordingtoseverityofcervicalneoplasiausingthedigenehpvgenotypinglqtest AT siderimario hpvgenotypedistributionaccordingtoseverityofcervicalneoplasiausingthedigenehpvgenotypinglqtest AT sandrimariateresa hpvgenotypedistributionaccordingtoseverityofcervicalneoplasiausingthedigenehpvgenotypinglqtest |